We have more and better data than ever, yet clinical success is in decline.
The exponential increase of public knowledge does not translate into clinical trial success. The last decades were full of scientific breakthroughs. Over 100,000 human genomes were sequenced to date, new technologies such as CRISPR-CAS9 enable scientists to produce more high-quality data than ever. What stops us from converting that data into actionable insights for treatment options? The human capacity to cut through the vast data repositories and draw the right connections is limited. OccamzRazor is solving this problem.
More papers are published every year than any human can read and keep in mind. Conversely, clinical trials in diseases of the central nervous system (CNS) are failing at increasing rates, leaving patients of complex diseases with no options for curative treatment.